![](/img/cover-not-exists.png)
Cost Effectiveness of First-Line Oral Antiviral Therapies for Chronic Hepatitis B
María Buti,Itziar Oyagüez,Virginia Lozano,Miguel A. CasadoVolume:
31
Language:
english
Journal:
PharmacoEconomics
DOI:
10.1007/s40273-012-0009-2
Date:
January, 2013
File:
PDF, 349 KB
english, 2013